Bubs share price tumbles 5% amid broker downgrade

Bubs shares are heading south on Tuesday…

| More on:
person holding hand to head in despair while holding a glass of milk with the other hand.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Bubs shares are giving back some of Monday's impressive gains
  • Its shares rocketed higher on news of a deal with the US Government for 1.25 million tins of infant formula
  • A leading broker has downgraded Bubs shares today largely on valuation grounds after the strong gain

The Bubs Australia Ltd (ASX: BUB) share price has run out of steam on Tuesday morning.

At the time of writing, the infant formula company's shares are down 5% to 64.5 cents.

Why is the Bubs share price sinking today?

There appear to be a couple of catalysts for the weakness in the Bubs share price on Tuesday.

The first is profit taking after a stellar gain on Monday following news that the company has struck a deal with the Biden Administration to supply 1.25 million tins of infant formula to help with shortages in the United States.

The market's reaction was so positive that the Bubs share price remains up 33% this week despite today's decline.

What else is weighing on its shares?

Also potentially weighing on the Bubs share price is a broker note out of Bell Potter this morning.

According to the note, the broker has downgraded the company's shares to a (speculative) hold rating with an improved price target of 75 cents.

Bell Potter was pleased with the aforementioned news but highlights that the US FDA's infant formula enforcement discretion policy (IFEDP) is only in place effect until November. As such, it is treating this development largely as a temporary sales boost. It said:

The IFEDP is only in effect until Nov'22 and in this light we have treated this largely as a temporary sales boost, with additional toddler formula sales thereafter.

Though, the broker does acknowledge that the announcement should boost brand awareness in the US, which is a market it believes could be very lucrative for Bubs. It explained:

At the very least the announcement de-risks near term sales forecasts for BUB, which are premised on execution against the Alpha Group equity linked distribution deal announced earlier in the year.

It could also be a viewed as a positive signal for BUB's achieving future USFDA approval for its infant products and enhanced brand awareness for its existing toddler products which are already distributed in the US. The upside potential in the US is high, particularly the organic grass fed IMF product, where we have estimated in the past a 2.0-4.5m pa tin opportunity for similar products.

However, due to the strong rise in the Bubs share price, the broker doesn't believe the risk/reward on offer is enough to maintain a buy rating.

It concludes:

This is a good announcement for BUB and at the least will likely result in increased US brand awareness while benefiting near term cashflows. BUB remains a high ceiling growth play in the IMF, however, in light of the recent share price gain we downgrade our rating from Buy, Speculative risk to Hold, Speculative risk.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BUBS AUST FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Ecstatic woman looking at her phone outside with her fist pumped.
Broker Notes

These ASX 200 shares could rise 15% to 30%

Let's see what brokers are saying about these buy-rated top stocks.

Read more »

A female stockbroker reviews share price performance in her office with the city shown in the background through her windows
Broker Notes

JP Morgan initiates coverage of Guzman Y Gomez shares. What's its price target?

Does the broker expect Guzman Y Gomez to outperform?

Read more »

Happy man working on his laptop.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

Worker on a laptop at an oil and gas pipeline.
Energy Shares

Boss Energy shares have surged 93% since April. Here's what Macquarie expects now

Boss Energy shares remain a favourite for ASX short sellers. Are they in a for a payday or headed for…

Read more »

Business meeting to discuss buy now pay later platform
Broker Notes

Macquarie tips substantial upside for Steadfast shares

Steadfast is a high-quality business at an attractive valuation, according to the broker.

Read more »

A man and woman sit next to each other looking at each other and feeling excited and surprised after reading good news about their shares on a laptop.
Broker Notes

These ASX 200 shares could rise 55% to 65%

Analysts think these shares are dirt cheap at current levels.

Read more »

Young man with a laptop in hand watching stocks and trends on a digital chart.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Broker Notes

Why DroneShield, Nickel Industries, and CSL shares could be best buys

Let's see why Bell Potter is so bullish on these shares.

Read more »